APA (7th ed.) Citation

I, K., RW, T., HF, W., AH, B., IC, v. d. S., D, C., . . . MD, V. (2023). Safety and pharmacodynamic efficacy of eculizumab in aneurysmal subarachnoid hemorrhage (CLASH): A phase 2a randomized clinical trial. European stroke journal, 8(4), 1097. https://doi.org/10.1177/23969873231194123

Chicago Style (17th ed.) Citation

I, Koopman, et al. "Safety and Pharmacodynamic Efficacy of Eculizumab in Aneurysmal Subarachnoid Hemorrhage (CLASH): A Phase 2a Randomized Clinical Trial." European Stroke Journal 8, no. 4 (2023): 1097. https://doi.org/10.1177/23969873231194123.

MLA (9th ed.) Citation

I, Koopman, et al. "Safety and Pharmacodynamic Efficacy of Eculizumab in Aneurysmal Subarachnoid Hemorrhage (CLASH): A Phase 2a Randomized Clinical Trial." European Stroke Journal, vol. 8, no. 4, 2023, p. 1097, https://doi.org/10.1177/23969873231194123.